Navigation Links
Getting lost -- a newly discovered developmental brain disorder
Date:9/22/2008

Feeling lost every time you leave your home? You may not be as alone as you think.

Researchers at the University of British Columbia and Vancouver Coastal Health Research Institute recently documented the first case of a patient who, without apparent brain damage or cognitive impairment, is unable to orient within any environment. Researchers also believe that there are many others in the general population who may be affected by this developmental topographical disorder.

The study, published in the journal Neuropsychologia, and led by Giuseppe Iaria, a UBC Faculty of Medicine and VCH postdoctoral fellow, used functional magnetic resonance imaging (fMRI) together with behavioural studies to assess and characterize the navigational deficiencies of the patient, who is completely unable to orient within the environment, getting lost even within the neighborhood where the patient lived for many years.

"Imagine not being able to do the simplest of tasks such as finding your way home from the grocery store," says Iaria, who is affiliated with the Brain Research Centre. "Navigating and orienting in an environment are complex cognitive skills, involving parts of the brain used for memory, attention, perception, and decision-making. It also requires using at least two distinct types of memory systems."

The procedural memory system involves using landmarks, distances, or following stereotyped movements to move between locations. The spatial memory system is more complex. When moving through an environment familiar or not a person creates a mental representation of the environment, called a cognitive map. It is the ability to "create" and "read" these cognitive maps that enables a person to navigate by following a route without getting lost.

Brain malformations or lesions in parts of the brain important for navigation are known to cause navigation difficulties. However, no such defects or lesions in the patient's bra
'/>"/>

Contact: Catherine Loiacono
catherine.loiacono@ubc.ca
604-822-2644
University of British Columbia
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Getting better conference to address developments in neurocritical care
2. Brain surgery is getting easier on patients
3. Red Cross Getting Ahead of Fay as More Rain Falls Across State
4. More U.S. Women Getting Birth Control Services
5. Are You Getting Burned by Your Sunscreen?
6. Spray Cuts Kids Pain When Getting IVs
7. Saddle Up! Getting a Jump on Proper Horse Care
8. CA Legislatures Reform of Health Insurance Cancellations Resembles Insurance Industrys Own Plan; Insurers, Satisfied With Getting a Legal Edge Against Patients, Drop Opposition to the Bill
9. Most Asthmatics Arent Getting Flu Shot
10. Quit smoking message not getting air time in mental health care
11. 20 Million Kids Books Distributed, 25% of U.S. Children in Poverty Getting Books, 50,000 Doctors Trained: Three Key Milestones for Reach Out and Read

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...and dessert at the holiday table are even less of ...According to a new research report recently appear...ebj.org ), a diet that is high in fat and in sugar...our bodies to store too much fat. This means these... difficult task of converting high-fat and high-su...
(Date:11/30/2009)...J. Rappa, MD, explores the intricate connection be...Healing Heart to Soul: One Doctor’s Journey ...09). , Dallas, TX (Vocus)...o let go of negative emotions, whether caused by u...houlders. Oftentimes, this disease of the human sp...
(Date:11/30/2009)...ov. 30 EMD Serono, an affiliate of...hat it received a refuse to file letter from the U...ug Application (NDA) for Cladribine Tablets, EMD S...on of cladribine, as a therapy for relapsing forms...ill work closely with the FDA to fully understand ...
(Date:11/30/2009)...y help delay progression and reduce expenses, rese...ay News) -- Medical care for osteoarthritis patien...r, according to a new study. , Of that amount, ....1 billion in out-of-pocket costs. Annual insurer ... male patient. Women also have higher out-of-pocke...
(Date:11/30/2009)...ting a tumor without disturbing normal tissue pres...apies can be invasive and harsh. , Researchers a...y they might deliver the right therapy directly to...which specifically bind to living tumor tissue. ,...nt with liver cancer until they found the best mol...
Breaking Medicine News(10 mins):Health News:Western diets turn on fat genes 2Health News:Healing from the Inside Out: Compelling New Book Explores the Intricate Connection between Body, Soul, and Better Health 2Health News:EMD Serono Receives Refuse to File Letter from FDA on Cladribine Tablets New Drug Application 2Health News:EMD Serono Receives Refuse to File Letter from FDA on Cladribine Tablets New Drug Application 3Health News:Osteoarthritis Costs U.S. Over $185 Billion a Year 2Health News:First live targeting of tumors with RNA-based technology 2Health News:First live targeting of tumors with RNA-based technology 3
...ic status and non-white race linked to worse outco...-- Minority children and those in poorer neighborh... transplant than white children or those in better...transplant at Children,s Hospital Boston between 1...
...essens worries more than usual care, study finds, ...For older adults, anxiety is an increasingly commo...e behavior therapy may help them ease their worrie...wer depressive symptoms and improved general menta...
... modest, but activity is safe and should be urged,...Day News) -- A regular program of moderate exercis...ably will benefit some of them, a new study has fo...United States, Canada and France. , Some were star...
...and dads snap thousands of photos, recording every...il now, this frenzy of activity could be one more ...ild,s health and developmental progress. , Now Ju... at the same time tracks a child,s developmental m...
...inn. Mayo Clinic researchers have discovered the ...th and development factors that may ultimately al...r cells or stop them from further development. The...that p21-activated kinase 2 (PAK2), a key target f...
...N.Y., April 7 Misonix, Inc. (Nasdaq: MSON ), a ... device technology, which in Europe is used for th... health conditions, announced that it has sold it...ndustrial ultrasonic equipment and recorded approx...
Other Medicine News:Health News:Heart Transplant Failures More Likely in Poor, Minority Kids 2Health News:Cognitive Behavior Therapy Eases Anxiety for Older People 2Health News:Cognitive Behavior Therapy Eases Anxiety for Older People 3Health News:Exercise Might Benefit Some With Heart Failure 2Health News:Exercise Might Benefit Some With Heart Failure 3Health News:Digital album puts focus on kids' health 2Health News:Digital album puts focus on kids' health 3Health News:Mayo researchers discover mechanism of cell type-specific signaling in tumor development 2Health News:Misonix Announces the Sale of Its Ultrasonic Laboratory Business for $3.5 Million to iSonix LLC 2
(Date:11/30/2009)...N.J. and CHICAGO, Nov. 30 Today at...f the Radiological Society of North America (RSN...d the enrollment of the first patient in an intern...fficacy and safety of florbetaben (BAY 94-9172) PE... in the brain, which are a pathological hallmark o...
(Date:11/30/2009)...TEL AVIV, Israel, November 30 Opto...III(TM) dual channel microphone, the most advanced...l magnetic resonance imaging,(fMRI) environments. ... major step forward for fiber,optic microphone tec...r, with,low-latency adaptive noise cancelling. The...
(Date:11/30/2009)... INDIANAPOLIS, Nov. 30 T...roved Cymbalta® (duloxetine HCl) for the main...(GAD) in adults, Eli Lilly and Company (NYSE: LL...ety disorder can be a chronic illness, it is impor...ent option that is effective in both the acute and...
Breaking Medicine Technology:Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 2Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 3New Generation Noise Cancelling Optical Microphone Paves Way for Advanced Brain and Speech Research 2FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 2FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 3FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 4FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 5NuVasive to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference 53144 1NuVasive to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference 53144 2NuVasive to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference 53144 3Roxane Laboratories Inc Announces the Launch of Risperidone Oral Solution 1mg mL 53140 1Roxane Laboratories Inc Announces the Launch of Risperidone Oral Solution 1mg mL 53140 2Osteotech Resumes Shipments of Bulgarian Tissue 13259 1Osteotech Resumes Shipments of Bulgarian Tissue 13259 2Osteotech Resumes Shipments of Bulgarian Tissue 13259 3
...Potential of NeoVista,s Epi...9 NeoVista, Inc. made public,yesterday 18-month d...examining its novel epiretinal brachytherapy for t...generation (AMD) at the 41st Scientific Meeting of...tudy, which was initiated,to test the safety and e...
...icals,Inc. (Nasdaq: IDEV ) today announced that i...zation agreement with Teva Pharmaceutical Industri...oclone. Indevus previously,announced promising dat...d,multi-center Phase II trial in patients with per...duced a statistically significant benefit in,multi...
Other Medicine Technology:NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting 2NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting 3NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting 4Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering 2Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering 3Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering 4
Hardy Micro Dissector
Hardy Nasal Bivalve Specula
Landolt Hypophysectomie Instrument, Spoon
Hardy Pituitary Spoons
Medicine Products: